10-Q: Q3 2024 Earnings Report

SECNov 13 06:22 · Announcements

8-K: Biote Reports Third Quarter 2024 Financial Results Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages

SECNov 13 05:26

10-Q: Q2 2024 Earnings Report

SECAug 10 01:57 · Announcements

8-K: Biote Reports Second Quarter 2024 Financial Results Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance

SECAug 9 04:48

10-Q: Q1 2024 Earnings Report

SECMay 11 03:09 · Announcements

BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 8-K: Biote Reports Third Quarter 2023 Financial Results Achieves Progress in Test of Complementary Wellness Therapeutics Reiterates 2023 Financial Guidance

SECNov 8, 2023 06:10